Subscribe To
Lexeo Therapeutics Announces Pricing of Initial Public Offering
NEW YORK, Nov. 02, 2023 (GLOBE NEWSWIRE) — Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to transforming healthcare by applying pioneering science to fundamentally change how genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s disease are treated, today announced the pricing of its initial public offering of 9,090,910 shares of common […] The post Lexeo Therapeutics Announces Pricing of Initial Public Offering appeared first...
Read More
Posted: Nov 3 2023, 01:51
Author Name: forextv
Views: 112298